Immunitybio Stock Momentum Indicators Average Directional Movement Index

Key Indicators . Data . Stocks . USA . 
Stock . Immunitybio
IBRX Stock  USD 7.76  -0.62  -7.40%   
Average Directional Movement Index indicator measures the rate and magnitude of price change in Immunitybio, measuring whether buying or selling pressure is accelerating or fading for Immunitybio, translating raw price data into a structured signal. Please specify Time Period to run this model.

Indicator
Time Period
Execute Indicator
This analysis covers fourteen data points across the selected time horizon. The average directional index (ADX) measures the strength of a prevailing trend of Immunitybio and whether movement exists in the market. The ADX is measured on a scale of 0 to 100. A low Immunitybio ADX value usually indicates a non-trending market with low volumes, whereas a cross above 20 may indicate the start of a trend. If the ADX is over 40 and begins to fall, it can indicate the slowdown of a current trend. This indicator can also be used to identify non-trending markets, or a deterioration of an ongoing trend. Although market direction is important in its calculation, the ADX is not a directional indicator

Immunitybio Technical Analysis Modules

Technical analysis of Immunitybio uses historical price and volume data to identify patterns that may signal where the Immunitybio trend is heading. Cycle indicators inform entry timing, while momentum indicators gauge the strength of the move.
Cycle Indicators
Math Operators
Math Transform
Momentum Indicators
Overlap Studies
Pattern Recognition
Price Transform
Statistic Functions
Volatility Indicators
Volume Indicators

Technical Indicator Methodology & Signal Interpretation

Momentum indicators measure the rate and magnitude of price change for Immunitybio, signaling whether buying or selling pressure is accelerating. Signal reliability depends on market regime and liquidity conditions.

Immunitybio metrics draw on periodic company reporting and market reference feeds, standardized for cross-period comparison.

Editorial review and methodology oversight provided by: Gabriel Shpitalnik, Member of Macroaxis Editorial Board

Tools
Analysis
Directory
Company
2026 Macroaxis LLC Made with in San Francisco
Privacy Terms Widgets Feedback
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and conditions page.